Corteva Inc. Common Stock vs Definium Therapeutics Inc. Common Shares — how do they compare? Corteva Inc. Common Stock trades at $13.25 (market cap $9.17B), while Definium Therapeutics Inc. Common Shares trades at $37.62 (market cap $4.59B). The key difference: Corteva Inc. Common Stock is the larger of the two by market cap, and Corteva Inc. Common Stock pays a 5.24% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and Definium Therapeutics Inc. Common Shares for 0 Days on average.
| CTVA | DFTX | |
|---|---|---|
Market Cap | $9.17B | $4.59B |
Volume | 35,183,471 | 2,103,937 |
Sector | Basic Materials | Health |
52-Week High | $90.51 | $48.45 |
52-Week Low | $11.92 | $10.68 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.68B | $3.55B |
Dividend Yield | 5.24% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.
Read more on CTVA →Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →